Acute phase Peyronies disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation
Conditions like irritable bowel syndrome (IBS), spinal issues, or neurological disorders can cause both constipation and back pain
Researchers may analyze receptor engagement profiles, pharmacology readouts, and biomarker changes in controlled model systems and clinical study frameworks
Of 274 participants, 91% reported reduced overall food cravings at six weeks
Cardiovascular benefit: In adults with type 2 diabetes who have established cardiovascular risk, a GLP-1 RA may provide cardiovascular benefit, independent of baseline A1C
Improved Metabolic Health: Tirzepatide helps improve overall metabolic health by controlling blood sugar levels and reducing insulin resistance